Implications of China withholding avian flu information

Published: August 30, 2018
Font Size

Article body

Dr. Spencer Durham of Auburn University’s Harrison School of Pharmacy can offer insight into the possible implications of China withholding samples of a virulent strain of the avian flu. He serves as an Assistant Clinical Professor in the Department of Pharmacy Practice and can help answer:

  • Why does China play a pivotal role in studying influenza?

  • Why withholding information from the United States could cause problems?

  • What is the influenza outlook this year for the United States?

  • What are some tips for people in preparation of flu season?

Durham is a board certified pharmacotherapy specialist and was awarded an added qualification in infectious diseases from the Board of Pharmacy Specialties. His areas of scholarly interest include antimicrobial stewardship, the treatment of multidrug-resistant organisms (MDRO), and the safety and efficacy of vancomycin.


To arrange an interview, please contact Preston Sparks, director of communications, at 334-844-9999 or

Media Note
The Auburn University Studio at Tichenor Hall is available for live HD video interviews with Auburn University experts through LTN Global Networks. If you are with a media outlet that is a member of LTN and would like to schedule a live interview about this story, visit our LTN webpage for more details.